We are very excited to announce preliminary research results, supported by the PRECAST project of the Science Fund of the Republic of Serbia, PROMIS program, as well as the EU-funded project NANOFACTS, from the Horizon2020 program. We have successfully prepared silica nanoparticles for on-demand pH-responsive drug release in a weakly acidic tumor microenvironment. These preliminary results have been demonstrated in vitro for cancer treatment and recently published in the journal Pharmaceutics.

Find out more: https://www.mdpi.com/1999-4923/13/4/460?fbclid=IwAR2gf1v3TEhwHQIrzckJctOrHZs81g9_YDvr-52e58PW4IUHZAGyd33uygQ